Literature DB >> 9739054

Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells.

T J Kelley1, M L Drumm.   

Abstract

It has been reported that exhaled nitric oxide levels are reduced in cystic fibrosis (CF) patients. We have examined the inducible isoform of nitric oxide synthase (iNOS) in the airways by immunostaining and found that iNOS is constitutively expressed in the airway epithelia of non-CF mouse and human tissues but essentially absent in the epithelium of CF airways. We explored potential consequences of lost iNOS expression and found that iNOS inhibition significantly increases mouse nasal trans-epithelial potential difference, and hindered the ability of excised mouse lungs to prevent growth of Pseudomonas aeruginosa. The absence of continuous nitric oxide production in epithelial cells of CF airways may play a role in two CF-associated characteristics: hyperabsorption of sodium and susceptibility to bacterial infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9739054      PMCID: PMC509103          DOI: 10.1172/JCI2357

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells.

Authors:  B H Koller; H S Kim; A M Latour; K Brigman; R C Boucher; P Scambler; B Wainwright; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Immunocytochemical localization of the cystic fibrosis gene product CFTR.

Authors:  I Crawford; P C Maloney; P L Zeitlin; W B Guggino; S C Hyde; H Turley; K C Gatter; A Harris; C F Higgins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

3.  Sensitivity of bacteria to NaNO2 and to L-arginine-dependent system in murine macrophages.

Authors:  S Saito; K Onozuka; H Shinomiya; M Nakano
Journal:  Microbiol Immunol       Date:  1991       Impact factor: 1.955

Review 4.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

5.  Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells.

Authors:  D B Light; E M Schwiebert; K H Karlson; B A Stanton
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Reduced upper airway nitric oxide in cystic fibrosis.

Authors:  I M Balfour-Lynn; A Laverty; R Dinwiddie
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

8.  An animal model for cystic fibrosis made by gene targeting.

Authors:  J N Snouwaert; K K Brigman; A M Latour; N N Malouf; R C Boucher; O Smithies; B H Koller
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

9.  Effects of PTH, ADH, and cyclic AMP on distal tubular Ca and Na reabsorption.

Authors:  L S Costanzo; E E Windhager
Journal:  Am J Physiol       Date:  1980-11

10.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

View more
  56 in total

1.  In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium.

Authors:  T J Kelley; H L Elmer
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Cystic fibrosis in adults: current and future management strategies.

Authors:  Brian M Morrissey; Bettina C Schock; Gregory P Marelich; Carroll E Cross
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

3.  Microarray analysis and functional characterization of the nitrosative stress response in nonmucoid and mucoid Pseudomonas aeruginosa.

Authors:  Aaron M Firoved; Simon R Wood; Wojciech Ornatowski; Vojo Deretic; Graham S Timmins
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

4.  Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis.

Authors:  J D Antuni; S A Kharitonov; D Hughes; M E Hodson; P J Barnes
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

5.  Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis.

Authors:  J C Ojoo; S A Mulrennan; J A Kastelik; A H Morice; A E Redington
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

Review 6.  The innate immune system in cystic fibrosis lung disease.

Authors:  R Bals; D J Weiner; J M Wilson
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

7.  New vascular insights into premature aging.

Authors:  Charles J Lowenstein; J Allen Bennett
Journal:  J Clin Invest       Date:  2018-12-18       Impact factor: 14.808

Review 8.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

9.  Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation.

Authors:  H Marteus; D C Törnberg; E Weitzberg; U Schedin; K Alving
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

10.  Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.

Authors:  Anna L P Chapman; Brian M Morrissey; Vihas T Vasu; Maya M Juarez; Jessica S Houghton; Chin-Shang Li; Carroll E Cross; Jason P Eiserich
Journal:  J Cyst Fibros       Date:  2010-01-15       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.